GET THE APP

Endocrinology & Metabolic Syndrome

Endocrinology & Metabolic Syndrome
Open Access

ISSN: 2161-1017

Perspective - (2023)Volume 12, Issue 4

Growth Hormone in Health and Disease: Insights into Disorders of the Endocrine System

Tsuyoshi Okura*
 
*Correspondence: Tsuyoshi Okura, Department of Endocrinology and Metabolism, University of Miami, Coral Gables, USA, Email:

Author info »

Description

Growth hormone, also known as somatotropin, is a peptide hormone produced by the anterior pituitary gland. GH plays a pivotal role in regulating growth, metabolism, and various physiological processes throughout life. The actions of GH are mediated through its interaction with the GH receptor and the subsequent activation of signaling pathways. Disruptions in GH action can lead to a range of human disorders, both in terms of growth and metabolism. In this article, we will explore the physiology of GH action and the associated human disorders.

Physiology of GH action

The actions of GH can be broadly categorized into two main areas: Growth-promoting effects and metabolic effects.

Growth promoting effects: Stimulation of growth plate chondrocytes is one of the primary functions of GH is to stimulate the proliferation and differentiation of chondrocytes (cartilage cells) in the growth plates of long bones. This leads to longitudinal bone growth, which is most prominent during childhood and adolescence.

Stimulation of IGF-1 production: GH promotes the synthesis and secretion of insulin-like growth factor-1 by the liver and other tissues. IGF-1 is a key mediator of GH's growth-promoting effects on bone and soft tissues.

Tissue growth: GH also exerts direct effects on various tissues, promoting cellular growth and differentiation. It influences the size and number of cells in muscles, organs, and connective tissues.

Metabolic effects

Lipolysis: GH enhances the breakdown of stored fat (lipolysis) and the release of fatty acids into the bloodstream. This can lead to increased utilization of fat as an energy source.

Carbohydrate metabolism: GH can reduce the uptake of glucose by cells, helping to maintain blood glucose levels. It also promotes glycogenolysis (the breakdown of glycogen into glucose) in the liver.

Protein synthesis: GH enhances protein synthesis in various tissues, contributing to muscle growth and tissue repair.

Enhanced IGF-1 production: IGF-1, stimulated by GH, also plays a role in metabolic regulation. It influences glucose uptake by cells and has insulin-like effects.

GH action and associated disorders

Disorders related to GH action can result from abnormalities at different levels of the GH axis, including the pituitary gland, the GH receptor, and downstream signaling pathways. Here are some of the key disorders associated with GH action:

Growth hormone deficiency: GHD is characterized by inadequate GH production or secretion. It can result from congenital factors, acquired conditions, or genetic mutations affecting the GH gene. GHD in children can lead to growth failure and short stature if left untreated. In adults, GHD may cause changes in body composition, reduced bone density, and altered lipid profiles.

Laron syndrome: Laron syndrome is a rare genetic disorder characterized by GH resistance. Individuals with Laron syndrome have normal or elevated levels of GH but lack functional GHRs. As a result, they exhibit severe growth retardation and other metabolic abnormalities. Treatment with recombinant IGF-1 can partially mitigate the growth impairment.

Gigantism: Gigantism is a rare condition that occurs when excessive GH is produced during childhood or adolescence, before the growth plates in the long bones have fused. This results in abnormal height and gigantism-related health issues.

Turner syndrome: Girls with Turner syndrome have only one X chromosome or partial loss of the second X chromosome. This condition often leads to short stature and can be associated with GH deficiency. GH therapy is commonly used to increase height in girls with Turner syndrome.

Prader-Willi syndrome: Prader-Willi syndrome is a genetic disorder characterized by chronic overeating, obesity, and developmental delays. GH therapy is sometimes used to improve growth and body composition in individuals with this syndrome.

Treatment of GH related disorders

The treatment of GH-related disorders often involves hormone replacement therapy with recombinant human GH. This therapy can stimulate growth and improve metabolic parameters in individuals with GH deficiency, Turner syndrome, and other conditions.

For conditions like acromegaly and gigantism, the primary treatment is typically surgical removal or irradiation of the pituitary tumor causing excessive GH production. Additional treatments may be required to manage the long-term metabolic effects of excess GH.

Conclusion

Growth hormone plays a central role in regulating growth, metabolism, and tissue maintenance. Disorders related to GH action can have profound effects on an individual's growth and overall health. Understanding the physiology of GH action and the associated disorders is essential for the diagnosis and management of these conditions, allowing individuals with GHrelated disorders to receive appropriate treatment and support.

Author Info

Tsuyoshi Okura*
 
Department of Endocrinology and Metabolism, University of Miami, Coral Gables, USA
 

Citation: Okura T (2023) Growth Hormone in Health and Disease: Insights into Disorders of the Endocrine System. Endocrinol Metab Syndr. 12:390.

Received: 21-Nov-2023, Manuscript No. EMS-23-27437; Editor assigned: 23-Nov-2023, Pre QC No. EMS-23-27437 (PQ); Reviewed: 07-Dec-2023, QC No. EMS-23-27437; Revised: 14-Dec-2023, Manuscript No. EMS-23-27437 (R); Published: 21-Dec-2023 , DOI: 10.35248/2161-1017.23.12.390

Copyright: © 2023 Okura T. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top